Bruker Corp BRKR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$92.99M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 62.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 7.74% to 7.38% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Barrow, Hanley, Mewhinney & Strauss, LLC | Mutual Fund | 2026/Q3 | +1,014,293 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +382,104 | 7.7% |
| Brooklands Fund Management Limited | Hedge Fund | 2026/Q3 | +309,800 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +245,109 | 9.9% |
| Barclays PLC | Public Company | 2026/Q3 | +155,489 | 0.2% |
| Tairen Capital Limited | Hedge Fund | 2026/Q3 | +130,000 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +131,798 | 0.1% |
| FMR | Mutual Fund | 2026/Q3 | +3,594,691 | 9.8% |
| Sachem Head Capital Management LP | Hedge Fund | 2026/Q3 | +2,915,000 | 1.9% |
| Sculptor Capital Management, Inc. | Hedge Fund | 2026/Q3 | +1,355,000 | 3.0% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +1,211,173 | 1.6% |
| Viking Global Investors LP | Hedge Fund | 2026/Q3 | +893,491 | 0.6% |
| Steadfast Capital Management LP | Hedge Fund | 2026/Q3 | +654,700 | 0.4% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +653,007 | 0.9% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +572,931 | 1.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Mark Munch | Corporate Executive VP & President of Bruker Nano Group | Derivative Exercise and Sale | -2,000 | $52.87 | 92,026 |
| 16 Aug 2026 | Wolfgang Pusch | Open Market Disposition | -3,473 | $56.90 | 6,681 | |
| 14 Aug 2026 | Frank Laukien | Chairperson & CEO | Sale to Issuer | -4,760 | $57.70 | 40,421,551 |
| 14 Aug 2026 | Frank Laukien | Chairperson & CEO | Other Acquisition | +29,463 | – | 89,570 |
| 14 Aug 2026 | Frank Laukien | Chairperson & CEO | Other Derivative Acquisition | +71,651 | $63.47 | 71,651 |
| 14 Aug 2026 | Mark Munch | Corporate Executive VP & President of Bruker Nano Group | Sale to Issuer | -2,984 | $57.70 | 92,026 |
| 14 Aug 2026 | Mark Munch | Corporate Executive VP & President of Bruker Nano Group | Other Acquisition | +14,443 | – | 42,780 |
| 14 Aug 2026 | Mark Munch | Corporate Executive VP & President of Bruker Nano Group | Other Derivative Acquisition | +11,708 | $57.70 | 11,708 |
| 14 Aug 2026 | Gerald Herman | Chief Financial Officer | Sale to Issuer | -2,724 | $57.70 | 61,062 |
| 14 Aug 2026 | Gerald Herman | Chief Financial Officer | Other Acquisition | +15,794 | – | 50,292 |
| 14 Aug 2026 | Gerald Herman | Chief Financial Officer | Other Derivative Acquisition | +12,803 | $63.47 | 12,803 |
| 14 Aug 2026 | Burkhard Prause | President and CEO of Bruker Energy & Supercon Technologies, Inc. | Other Acquisition | +3,303 | – | 9,267 |
| 14 Aug 2026 | Burkhard Prause | President and CEO of Bruker Energy & Supercon Technologies, Inc. | Other Derivative Acquisition | +2,678 | $57.70 | 2,678 |
| 14 Aug 2026 | Juergen Srega | President of Bruker Biosystems Group & Bruker Daltonics Division | Other Acquisition | +16,898 | – | 29,040 |
| 14 Aug 2026 | Juergen Srega | President of Bruker Biosystems Group & Bruker Daltonics Division | Other Derivative Acquisition | +13,698 | $57.70 | 13,698 |
| 14 Aug 2026 | Thomas Bures | Chief Accounting Officer | Other Acquisition | +4,035 | – | 6,264 |
| 14 Aug 2026 | Wolfgang Pusch | Other Acquisition | +3,120 | – | 3,120 | |
| 14 Aug 2026 | Wolfgang Pusch | Other Derivative Acquisition | +2,529 | $57.70 | 2,529 | |
| 13 Aug 2026 | Mark Munch | Corporate Executive VP & President of Bruker Nano Group | Derivative Exercise and Sale | -2,000 | $57.60 | 92,026 |
| 10 Aug 2026 | Frank Laukien | Chairperson & CEO | Sale to Issuer | -4,838 | $57.02 | 40,414,203 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 11,251,178 | 7.4% | 5.4 |
| 15 Oct 2026 | 12,673,281 | 8.3% | 5.7 |
| 30 Sep 2026 | 12,406,174 | 8.1% | 5.1 |
| 15 Sep 2026 | 12,490,387 | 8.2% | 6.3 |
| 31 Aug 2026 | 12,005,384 | 7.9% | 6.3 |
| 14 Aug 2026 | 11,785,398 | 7.7% | 4.0 |
No comments yet — be the first to weigh in on BRKR.
Sign in to join the discussion.